Atossa Therapeutics (ATOS) Tax Rate (2020 - 2025)
Atossa Therapeutics (ATOS) posted quarterly Tax Rate of 84.39% for Q4 2024, down 5.77% quarter-over-quarter from 89.55% in Q4 2021.
Atossa Therapeutics (ATOS) Tax Rate (2020 - 2025) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Tax Rate for 3 consecutive years, with 84.39% the latest figure, recorded in Q4 2024.
- In Q4 2024, Tax Rate changed N/A year-over-year to 84.39%; the TTM figure through Sep 2025 stood at 17.75% (changed N/A YoY), while the FY2024 annual figure was 21.0%, changed N/A from the prior year.
- Tax Rate retreated to 84.39% in Q4 2024 per ATOS's latest filing, from 89.55% in the prior quarter.
- Across five years, Tax Rate topped out at 89.55% in Q4 2021 and bottomed at 50.03% in Q4 2020.
- Historically, Tax Rate has averaged 74.66% across 3 years, with a median of 84.39% in 2024.
- On a YoY basis, Tax Rate climbed as much as 3952 bps in 2021 and fell as far as 3952 bps in 2021.
- Atossa Therapeutics' Tax Rate stood at 50.03% in 2020, then jumped by 79 bps to 89.55% in 2021, then decreased by 6 bps to 84.39% in 2024.
- Business Quant data shows ATOS's Tax Rate at 84.39% in Q4 2024, 89.55% in Q4 2021, and 50.03% in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 7.49% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.71% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 34.12% |
| 10 | Atossa Therapeutics | 23.16 Mn | 23.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.76% |
| Dec 31, 2025 | 66.76% |
| Dec 31, 2025 | 66.76% |
| Dec 31, 2024 | 84.39% |
| Dec 31, 2024 | 84.39% |
| Dec 31, 2024 | 84.39% |
| Dec 31, 2021 | 89.55% |
| Dec 31, 2021 | 89.55% |
| Dec 31, 2021 | 89.55% |
| Dec 31, 2020 | 50.03% |
| Dec 31, 2020 | 50.03% |
| Dec 31, 2020 | 50.03% |